Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 210
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(20))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1

+ Details

Name:	us-gaap_AccruedLiabilitiesCurrent
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Excludes Selling, General and Administrative Expense.

+ References

No definition available.

+ Details

Name:	us-gaap_OperatingCostsAndExpenses
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Carrying value as of the balance sheet date of obligations incurred through that date and due beyond one year (or beyond one operating cycle if longer) for milestone and royalty payments.

+ References

No definition available.

+ Details

Name:	ymab_AccruedMilestoneAndRoyaltyPaymentsNoncurrent
Namespace Prefix:	ymab_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Amount of cash payments under arrangement other than collaborative.

+ References

No definition available.

+ Details

Name:	ymab_ArrangementOtherThanCollaborativeCashPayments
Namespace Prefix:	ymab_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Represents the maximum clinical milestone payments entity is obligated to pay under arrangement other than collaborations.

+ References

No definition available.

+ Details

Name:	ymab_ArrangementOtherThanCollaborativeClinicalMilestonePaymentsDue
Namespace Prefix:	ymab_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Represents the maximum regulatory milestone payments entity is obligated to pay under arrangement other than collaborative.

+ References

No definition available.

+ Details

Name:	ymab_ArrangementOtherThanCollaborativeRegulatoryMilestonePaymentsDue
Namespace Prefix:	ymab_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Represents the maximum sales based milestones payments entity is obligated to pay under arrangement other than collaborative.

+ References

No definition available.

+ Details

Name:	ymab_ArrangementOtherThanCollaborativeSalesBasedMilestonePaymentsDue
Namespace Prefix:	ymab_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- References

No definition available.

+ Details

Name:	ymab_FinancialStatementInformationAbstract
Namespace Prefix:	ymab_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

- References

No definition available.

+ Details

Name:	ymab_MilestonesAbstract
Namespace Prefix:	ymab_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

- Details

Name:	us-gaap_TypeOfArrangementAxis=ymab_LicenseAgreementMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_CounterpartyNameAxis=ymab_MskMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_CounterpartyNameAxis=ymab_MskAndMabvaxMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_TypeOfArrangementAxis=ymab_Cd33LicenseAgreementMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_TypeOfArrangementAxis=ymab_SadaLicenseAgreementMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_CounterpartyNameAxis=ymab_MskAndMitMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

LICENSE AGREEMENTS AND COMMITMENTS - Summary of Significant Agreements and Commitments (Details) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023	Dec. 31, 2023
Financial statement information
Accrued liabilities, current	$ 12,788,000		$ 12,788,000		$ 13,166,000
Accrued liabilities, noncurrent	3,950,000		3,950,000		5,375,000
License Agreement \| MSK
Milestones
Maximum Clinical Milestones	2,450,000		2,450,000
Maximum Regulatory Milestones	9,000,000		9,000,000
Maximum Sales-based Milestones	20,000,000		20,000,000
Financial statement information
Cash paid	2,377,000	$ 3,245,000
Expense	1,503,000	1,479,000	2,887,000	$ 2,702,000
Accrued liabilities, current	2,962,000		2,962,000		2,452,000
Accrued liabilities, noncurrent	1,950,000		1,950,000		1,950,000
License Agreement \| MabVax
Milestones
Maximum Clinical Milestones	200,000		200,000
Maximum Regulatory Milestones	1,200,000		1,200,000
Financial statement information
Expense	10,000		10,000
Accrued liabilities, current	10,000		10,000
CD33 License Agreement \| MSK
Milestones
Maximum Clinical Milestones	550,000		550,000
Maximum Regulatory Milestones	500,000		500,000
Maximum Sales-based Milestones	7,500,000		7,500,000
Financial statement information
Accrued liabilities, noncurrent	300,000		300,000		300,000
SADA License Agreement \| MSK and MIT
Milestones
Maximum Clinical Milestones	4,730,000		4,730,000
Maximum Regulatory Milestones	18,125,000		18,125,000
Maximum Sales-based Milestones	23,750,000		23,750,000
Financial statement information
Cash paid	875,000	$ 605,000
Accrued liabilities, current	1,550,000		1,550,000		1,000,000
Accrued liabilities, noncurrent	$ 1,700,000		$ 1,700,000		$ 3,125,000